Dear Health Care Provider Letters: Improving Communication of Important Safety Information
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 2, 2014
April 24, 2023
a3ea6356-848d-4286-86e9-8ac6013377e1
Related Documents
Expedited Programs for Serious Conditions | Drugs and Biologics
Guidance DocumentMay 30, 2014Center for Drug Evaluation and Research
CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports
Guidance DocumentMarch 5, 2014Center for Drug Evaluation and Research
Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application
Guidance DocumentAugust 2, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox